饲粮中添加硫胺素缓解奶牛亚急性瘤胃酸中毒的研究进展

亚急性瘤胃酸中毒(SARA)是一种常见的奶牛营养代谢病,严重影响了养殖业的经济效益。硫胺素是奶牛所需的营养物质,在奶牛饲粮中添加硫胺素可缓解SARA,提高瘤胃液pH,维持瘤胃内环境稳态。本文综述了硫胺素的生物学功能及硫胺素对SARA奶牛瘤胃微生物区系、代谢产物及瘤胃上皮屏障功能的影响,为硫胺素在奶牛生产中的应用提供参考。     

饲粮中添加硫胺素缓解奶牛亚急性瘤胃酸中毒的研究进展北大核心CSCD

亚急性瘤胃酸中毒(SARA)是一种常见的奶牛营养代谢病,严重影响了养殖业的经济效益。硫胺素是奶牛所需的营养物质,在奶牛饲粮中添加硫胺素可缓解SARA,提高瘤胃液pH,维持瘤胃内环境稳态。本文综述了硫胺素的生物学功能及硫胺素对SARA奶牛瘤胃微生物区系、代谢产物及瘤胃上皮屏障功能的影响,为硫胺素在奶牛生产中的应用提供参考。     

瘤胃异常代谢产物组胺影响反刍动物生产性能和瘤胃性能的研究现状

高精低粗的饲粮结构会引起奶牛瘤胃内乳酸和挥发性脂肪酸浓度升高,瘤胃液p H降低,导致瘤胃内微生物区系发生改变,引起瘤胃内异常代谢产物组胺增加。组胺可引起奶牛多种疾病,并使奶牛生产性能下降。本文综述了瘤胃异常代谢产物组胺的产生原因、相应作用机理,以及组胺对反刍动物的生产性能及瘤胃特性的影响。     

瘤胃微生物区系及其调控

瘤胃微生物区系变化与反刍动物的生长发育密切相关，微生物受宿主、环境、营养、管理等因素的影响，瘤胃微生物在反刍动物的生长发育、生产性能以及健康方面起着重要作用。本文综述了4种瘤胃微生物区系的建立过程与机制，以及微生物区系变化对动物代谢的影响，并阐述了瘤胃的调控技术与机理，为瘤胃调控技术应用、生产性能及健康水平提升、环境减排提供参考。     

烟酸对奶牛代谢和生产性能的影响

本文综述了烟酸的特点、营养作用机理;烟酸在奶牛体内代谢作用及对瘤胃微生物和瘤胃发酵的影响;烟酸对奶牛产奶性能、预防酮病的作用及奶牛生产中烟酸的需要量等多方面的研究。     

多组学技术在奶牛瘤胃微生物与宿主互作机制中的研究进展

对于反刍动物而言,瘤胃对宿主的新陈代谢、机体免疫调节具有重要的意义。作为瘤胃内强大而丰富的群落,瘤胃微生物结构紊乱不仅会导致生产性能下降,还会引发机体全身炎症反应。近年来,多组学技术分析瘤胃微生物与宿主的关系及其调控机制已逐渐受到研究者的关注。本文从瘤胃微生物的影响因素、多组学技术在瘤胃微生物中的应用及瘤胃微生物紊乱对宿主的影响等多方面进行综述,以通过调节瘤胃微生物来提高奶牛生产性能、增强机体免疫力以及预防疾病等新的视角为奶牛养殖者提供参考。     

奶牛瘤胃宏基因组学研究进展

瘤胃是成年奶牛的主要消化吸收器官，能够降解粗饲料、非蛋白氮等饲料。微生物大量存在于瘤胃，其组成、丰度、功能和代谢会影响奶牛的产奶和饲料转化效率等性状。本文介绍了宏基因组技术在微生物基因组组装、瘤胃微生物调控奶牛生产性状形成机制以及微生物新酶发现的研究进展，展望了奶牛瘤胃宏基因学发展前景，旨在为解析奶牛重要性状遗传与调控机制提供新思路。     

过瘤胃保护胆碱在奶牛生产中的应用

过瘤胃保护胆碱（RPC）可有效防止瘤胃微生物对胆碱的降解,使胆碱在理想部位即小肠释放进而被吸收。许多研究证实,RPC促进围产期奶牛健康,提高生产性能以及繁殖性能。本文系统综述了过瘤胃保护胆碱对奶牛代谢和生产性能的影响与作用机制,讨论了影响其添加效果的各种因素及胆碱过瘤胃技术的现状。     

益生菌对奶牛产奶量、乳成分及瘤胃微生物区系的影响

优质牛奶的充足供给需要以奶牛的健康养殖为基础。益生菌在奶牛饲料中的添加对奶牛的产奶量、乳成分和瘤胃微生态区系均有正面影响,可以通过增加奶牛瘤胃中有益微生物的含量,同时竞争性抑制有害菌的生长定殖,进而提高奶牛的机体健康状况和生产性能。本文对益生菌的功能、作用机制及在奶牛养殖中的应用效果进行阐述,旨在为益生菌的广泛应用提供参考。     

微生态制剂在奶牛生产中的作用

微生态制剂是一类根据微生态学原理制成的对动植物有益的活菌制剂,因具有无毒、无污染、无残留的特点,广泛应用于奶牛养殖业。研究表明,微生态制剂可以通过调节瘤胃微生物的动态平衡、调节瘤胃pH值的稳定、改变微生物在瘤胃中的发酵模式等方式提高反刍动物的生产性能,还可以预防奶牛乳房炎、子宫内膜炎等的发生,改善畜舍环境,并提高青贮质量。文章介绍了微生态制剂的分类、微生态制剂在奶牛生产中的作用以及微生态制剂的发展前景,旨在为微生态制剂在奶牛生产中的运用提供理论依据。     

Effects of Bacillus subtilis C‐3102 on production,hatching performance,egg quality,serum antioxidant capacity and immune response of laying breeders

To investigate the supplemental effects of Bacillus subtilis C‐3102 on the production, hatching performance, egg quality, serum antioxidant capacity and immune response of laying breeders, a total of 480 Xuefeng black‐bone (25‐week‐old) hens were randomly assigned into four treatment groups: Hens fed the basal diets with 0 (CON), 3.0 × 10⁵ (BS‐1), 6.0 × 10⁵ cfu/g (BS‐2) and 9.0 × 10⁵ (BS‐3) cfu/g of B. subtilis C‐3102. As the B. subtilis C‐3102 level increased, egg weight (linear, p < 0.01; quadratic, p = 0.003), fertility (linear, p = 0.021; quadratic, p = 0.059), hatchability (linear, p = 0.038; quadratic, p = 0.119) and yolk colour (linear, p = 0.006; quadratic, p = 0.021) increased in a linear or quadratic manner. Yolk index increased quadratically (linear, p = 0.054; quadratic, p = 0.017), and eggshell thickness (linear, p = 0.036; quadratic, p = 0.128), the activity of GSH‐Px (linear, p = 0.024; quadratic, p = 0.078), the concentration of IgM (linear, p = 0.016; quadratic, p = 0.056) and the level of AIV‐Ab (linear, p = 0.034; quadratic, p = 0.103) in the serum increased linearly as dietary supplementation of B. subtilis C‐3102 increased. The results showed that dietary treatments did not affect egg production, feed conversion ratio, egg mass, hatchability of fertile eggs, eggshell‐breaking strength, egg‐shape index, yolk percentage, Haugh unit, T‐SOD, T‐AOC, MDA, IgA and IgG concentrations and the level of NDV‐Ab in the serum. In conclusion, dietary supplementation of 9.0 × 10⁵ cfu/g B. subtilis C‐3102 in laying breeders diets may be a feasible means of effectively increasing egg weight, fertility and hatchability, and improving egg quality such as eggshell thickness, yolk index and yolk colour. Besides, B. subtilis C‐3102 can enhance the activity of GSH‐Px, the concentration of IgM and the level of AIV‐Ab in the serum.     

Dose-related antinociceptive effects of intravenous buprenorphine in cats

The dose-related antinociceptive effects of intravenous (IV) buprenorphine were evaluated in cats. Thermal (TT) and mechanical threshold (MT) devices were used for nociceptive stimulation. After baseline threshold recordings, buprenorphine was administered IV (0.01, 0.02 or 0.04 mg/kg; B1, B2 and B4, respectively) in a randomised, blinded and cross-over study. Data were analysed by ANOVA (P < 0.05) using 95% confidence intervals (CI). TT increased 15, 30, 45 min and 1 (5.2 ± 2.7 °C), 2, 3 and 4 h after B1; 15, 30, 45 min and 1 (5.1 ± 3.9 °C) and 2 h after B2, and 15, 30, 45 min and 1 (5.4 ± 3.3 °C), 2, 3, 6 and 8 h after B4. MT increased 15 and 45 min after B2 (260 ± 171 mmHg), and 30 (209 ± 116 mmHg) and 45 min and 1 and 2 h after B4. At 45 min, MT values were significantly higher after B2 compared to B1 (P < 0.05). With MT, B2 and B4 produced more antinociception and longer duration of action than B1, respectively. No dose response to thermal stimulation was detected.     

Effect of storage duration on egg quality,embryo mortality and hatchability in FUNAAB-ɑ chickens

Effect of extended storage on egg quality, embryo mortality and hatchability in FUNAAB-ɑ chickens was determined. Hatchable eggs (n = 288; weighing 53.2 ± 4.67 g) collected from a flock of FUNAAB-ɑ layer breeder hens aged 32 weeks were stored in egg tray with broad end up under 16 ± 1.5°C for either 0, 4, 8, 12, 16 or 20 d. Before incubation, eight eggs from each group were evaluated for internal and external quality traits. Remaining eggs were set in an incubator and transferred into hatcher on embryonic day 18. Data collected were subjected to one-way analysis of variance. Egg weight loss (EWL; p < .001), surface area (p < .001), yolk diameter (p < .001), inner and outer blastoderm diameters (p < .05) and dead in germ (DIG; p < .001) increased with storage duration while yolk height (p < .001), yolk index (p < .001), albumen weight (p < .05), albumen height (p < .05), albumen index (p < .01), Haugh's unit (HU; p < .05), fertility (p < .001), hatchability of set (HATCHS; p < .001) and fertile eggs (p < .05) decreased. Weight losses of 0, 1.2, 2.2, 3.4, 4.6 and 6.1% were recorded in egg stored for 0, 4, 8, 12, 16 and 20 days respectively. Eggs stored beyond 8 days exhibited higher DIG and lower HATCHS. Shell percentage in 4 days storage (11.4%) was lower (p < .05) than in 16 days storage (13.4%). Shell thickness was similar in eggs stored for 0 to 12 days, but 8 days storage (0.60 mm) had thinner (p < .01) shell than day 16 (0.71 mm) and day 20 (0.73 mm) storage. Internal quality unit (IQU) was higher (p < .05) in fresh eggs (180.4) than in 12 days (167.8) and 20 days (167.8) stored eggs. Extended storage of FUNAAB-ɑ eggs caused EWL, surface area shrinkage, lowered HU and IQU, loss of yolk and albumen quality, increased blastoderm diameters and DIG, and decreased egg fertility and HATCHS from day 8 forward. Storing FUNAAB-ɑ eggs beyond 8 days reduced quality parameters; therefore, other mitigating factors are recommended when storing beyond 8 days.     

Low‐density lipoproteins and milk serum proteins improve the quality of stallion sperm after vitrification in straws

Lipids and proteins can be used for sperm vitrification to preserve the integrity of sperm membranes or to increase the viscosity of the medium. This study evaluated the effect of low‐density lipoproteins (LDL) and milk serum proteins (Pronexcell) for stallion sperm vitrification. Hippex extender (Barex Biochemical Products, The Netherlands), plus 1% of bovine serum albumin and 100 mM of trehalose, was used as control for sperm vitrification. In experiment 1, different concentrations of LDL (L1 = 0.25, L2 = 0.5, L3 = 1%) and in experiment 2 of Pronexcell (P1 = 1, P2 = 5, P3 = 10%) were added to control extender. Vitrification was performed in 0.25‐ml straws directly plunged into liquid nitrogen. Total motility (TM, %) and progressive motility (PM, %) were analysed by CASA, and plasma membrane (IMS, %) and acrosome membrane integrity (AIS, %) were assessed under epifluorescence microscopy. Post‐warmed sperm parameters were compared between treatments by ANOVA. Results were expressed as mean ± SEM. In both experiments, the minimum concentration of LDL and Pronexcell obtained significantly higher values (p < 0.01) than the control extender for TM (L1 = 52.95 ± 4.4; P1 = 58.99 ± 4.6; C = 30.88 ± 3.0), PM (L1 = 36.79 ± 5.5; P1 = 47.25 ± 4.3; C = 19.20 ± 2.4), IMS (L1 = 68.88 ± 3.6; P1 = 47.25 ± 4.3; C = 52.81 ± 2.6) and AIS (L1 = 45.88 ± 3.6; P1 = 47.25 ± 4.3; C = 26.00 ± 2.1). No differences in sperm parameters were found among different concentrations of LDL or Pronexcell. In conclusion, the addition of 0.25% LDL and 1% Pronexcell to the vitrification extender is recommended to improve the quality of stallion sperm after vitrification.     

Betaine improves growth performance,liver health,antioxidant status,breast meat yield,and quality in broilers fed a mold-contaminated corn-based diet

Betaine has been demonstrated to improve growth performance and antioxidant status of animals under various stress conditions. However, there is no literature on the effects of betaine in animals exposed to mycotoxins, which are among the most prevalent contaminants in feed. Therefore, this study was conducted to evaluate the influence of dietary betaine on broilers fed a diet based on mold-contaminated corn (MCC). A total of 192 Ross 308 male broiler chicks at 1 d of age were randomly divided into 4 groups with 6 replicates and fed an MCC-based diet supplemented with 0, 250, 500, and 1,000 mg/kg betaine, respectively. Betaine increased average daily gain (linear, P = 0.030) and decreased feed conversion ratio (linear, P = 0.027) of broilers during d 1 – 21, and decreased feed conversion ratio during d 22 – 42 (linear, P = 0.012; quadratic, P < 0.001) and d 1 – 42 (linear, P = 0.003; quadratic, P = 0.004), whereas feed intake was not affected. Total cholesterol (linear, P = 0.024), alanine aminotransferase (quadratic, P < 0.001) and alkaline phosphatase (linear, P = 0.007; quadratic, P = 0.025) activities in serum were decreased by betaine. Betaine linearly increased breast muscle yield (P = 0.003) and pH_24 h (P = 0.008), and decreased drip loss (P = 0.022). Betaine increased (linear, P = 0.025; quadratic, P = 0.016) total superoxide dismutase activity in breast muscle and reduced malondialdehyde content in serum (linear, P = 0.006), liver (quadratic, P = 0.006) and breast muscle (linear, P = 0.003). Moreover, the zearalenone concentrations in breast muscle were linearly decreased by betaine (P = 0.006). It was concluded that betaine could improve growth performance, liver health, antioxidant status, and breast meat yield and quality, and reduce zearalenone residue in broilers fed the MCC-based diet, especially at 500 or 1,000 mg/kg.     

Comparison of the sedative effects of intranasal or intramuscular dexmedetomidine at low doses in healthy dogs: a randomized clinical trial

ObjectiveTo compare the sedative effects of dexmedetomidine administered either intranasally or intramuscularly to healthy dogs.Study designProspective, randomized, blinded, clinical trial.AnimalsA group of 16 client-owned healthy dogs.MethodsDogs were randomly allocated to one of two groups that were administered dexmedetomidine 5 μg kg^–1 via either the intranasal route (IN_Dex), through a mucosal atomization device in one nostril, or the intramuscular route (IM_Dex), into the epaxial muscles. Ease of intranasal administration, sedation score, onset of sedation, cardiopulmonary variables, mechanical nociceptive thresholds (MNTs) and response to venous catheterization were recorded at 0 (baseline), 5, 10, 15, 20, 25, 30, 35, 40 and 45 minutes, following drug administration. Data were compared with the one-way anova, Mann-Whitney U test, and chi-square test, where appropriate.ResultsGroups were not different for age, sex, weight, body condition score or temperament. Sedation scores, MNTs and response to intravenous catheter placement were not different when dexmedetomidine was administered by either route (p = 0.691; p = 0.630 and p = 0.435, respectively). Onset of sedation was not different between groups IN_Dex and IM_Dex reaching a score of 4.2 ± 0.9 and 5.5 ± 1.2 at 9 ± 5 and 8 ± 4 minutes, respectively (p = 0.467). The highest sedation score was achieved at 30 and 35 minutes and sedation scores were 9.7 ± 2.0 and 9.5 ± 2.3 in groups IN_Dex and IM_Dex, respectively (p = 0.799). Respiratory rate was higher in group IN_Dex (p = 0.014), while there were no differences between routes in heart rate (p = 0.275), systolic (p = 0.957), diastolic (p = 0.837) or mean arterial pressure (p = 0.921).Conclusions and clinical relevanceIntranasal administration of dexmedetomidine at 5 μg kg^–1 provides effective sedation in healthy dogs.     

A meta-analysis on effects of supplementing low-quality roughages with foliages from browses and tree fodders on intake and growth in sheep

A meta-analysis of data obtained from previous studies was conducted to understand the responses of foliage supplementation on intakes of basal DM (BDMI) and total DM (TDMI), and daily gain (ADG). Thirty-four published studies containing 223 treatments and 1127 sheep met criteria for inclusion in the meta-analysis. Major predictive variables considered were percentages of foliages in diet (SD), CP in foliages (PS), NDF in foliages (FS), NDF in forages (FB), CP in basal roughages (PB), CP in diet (PD) and foliage CP intake (SPI). TDMI (g/d) increased quadratically (P < 0.001) with increasing PS, FS, SPI (R² = 0.66), PB, SD (R² = 0.58) and PD (R² = 0.73). The maximal response of TDMI were 778 g/d at 42% of SD, 894 g/d at 19.8% PD, 893 g/d at 148 g/d SPI and 749 g/d at 26.4% PS (P < 0.001; R² = 0.58, 0.73, 0.66, and 0.37, respectively). BDMI increased quadratically with increasing SD, PD and PB, but decreased quadratically (P < 0.001) with increasing PS (P < 0.001; R² = 0.07). The breakpoint of BDMI was 570 g/d at 6.58% of PD in the diet (P < 0.001, R² = 0.28). Overall, BDMI responded at very low level of SD in the diet, peaking at 7.6% SD with BDMI of 572 g/d (P < 0.001, R² = 0.72). However, when PB was less than 3%, the maximal BDMI was 489 g/d at foliage levels of 25.7%. When PB was between 3 and 6%, maximal BDMI was at 13% of foliage in the diet and the basal forage intake of 597 g/d; whereas, BDMI decreased linearly with SD when PB was greater than 6%. BDMI (g/d) decreased quadratically when foliage CP percentages were lesser than 10%, but increased quadratically with PS when foliage CP percentages were greater than 10%. ADG responded positively and quadratically to PS, SPI, SD, PD and TDMI (g/d) and the relationships were moderate to high. However, ADG (g/d) decreased linearly with increasing FS (P < 0.001, R² = 0.35). The maximal ADG was 42 g/d at 43% of SD, 41 g/d at 9.4% PD, 42 g/d at 53 g/d SPI, 35 g/d at 25% PS and 46 g/d at TDMI of 889 g/d (P < 0.001; R² = 0.74, 0.84, 0.74, 0.29 and 0.74, respectively). It is concluded that the interactions of quality and quantity of foliage supplements and quality of basal forages affect intakes of basal and total DM, and growth in sheep.     

Influence of dietary lysine level on whole-body protein turnover, plasma IGF-I, GH and insulin concentration in growing pigs

Four growing pigs (initial liveweight 25.9 ± 0.54 kg, final liveweight 43.0 ± 1.06 kg) were used to study the effect of dietary lysine level on nutrient digestibility, whole-body protein turnover, plasma insulin-like growth factor-I (IGF-I), growth hormone (GH), insulin, glucose, and urea nitrogen (PUN). Four diets, containing 7.0 g (L1), 9.5 g (L2), 12.0 g (L3) and 14.5 g (L4) lysine per kg diet respectively, were formulated as experimental treatments. The animals and diets were allocated in a 4 × 4 Latin square design. Nitrogen (N) metabolism and whole-body protein turnover were measured by classical method and single-dose ¹⁵N end-product method, respectively. The blood samples were taken at the end of each experimental period. Results showed that N retention (NR) and N biological value (NBV) were significantly increased from L1 to L4 (P < 0.05). However, differences in NR and NBV between L2, L3 and L4 were not significant (P > 0.05). There was no significant difference on dry matter (DM) digestibility, organic matter (OM) digestibility and N digestibility between different treatments (P > 0.05). Whole-body protein synthesis, protein degradation and protein accretion increased markedly from L1 to L2 (P < 0.05), but did not increase further from L2 to L4. Whole-body protein accretion (y, g/kg W^0.75/d) increased with dietary lysine (x, g/kg) in a quadratic manner: y = − 0.09x² + 2.12x − 5.14 (r² = 0.96, n = 4, P < 0.05).The results also showed that differences in plasma IGF-I, GH, glucose and PUN concentration between different treatments were not significant (P > 0.05). Plasma insulin concentration (y, μIU/ml) was increased with dietary lysine (x, g/kg) in a quadratic manner: y = 0.23x² − 4.10x + 32.25 (r² = 0.99, n = 4, P < 0.05), but it was not found that plasma insulin concentration was related to NR. A significant correlation was found between NR (y, g/d) and plasma IGF-I (x, ng/ml): y = − 3.1 × 10^− 3x² + 1.31x − 122.28 (r² = 0.99, n = 4, P < 0.05).It was concluded that dietary lysine level had a significant influence on NR and whole-body protein turnover but not on plasma IGF-I and GH concentration. Plasma IGF-I may be an important factor controlling N metabolism of growing pigs. Further research was needed to study the mechanism.     

The effects of the supplementation of Bacillus subtilis RX7 and B2A strains on the performance,blood profiles,intestinal Salmonella concentration,noxious gas emission,organ weight and breast meat quality of broiler challenged with Salmonella typhimurium

An experiment was conducted to evaluate the effects of B. subtilis RX7 and B. subtilis B2A on growth performance, blood profiles, intestinal Salmonella population, noxious gas emission, organ weight and breast meat quality of broilers under S. typhimurium challenge. A total of 120, one‐day‐old Ross 308 male broiler chicks were assigned to four dietary treatments, composed of six replications, with five birds per replication, for 10 day. The dietary treatment groups were negative control (NC; no antibiotic, no B. subtilis), positive control (PC; NC + 0.1% virginiamycin), B. subtilis RX7 (NC + 0.1% B. subtilis RX7 1.0 × 10⁹ cfu/g) and B. subtilis B2A (NC + 0.1% B. subtilis 1.0 × 10⁹ cfu/g). All birds were orally challenged with 2 ml suspension, containing 10⁴ cfu/ml of S. typhimurium KCCM 40253. Results indicated that the body weight gain, feed intake and feed conversion did not differ, among all comparative treatments. Serum haptoglobin concentration was lower in Bacillus treatments (RX7 + B2A) than the NC treatment (p < 0.05). Intestinal and excreta Salmonella number, and excreta ammonia gas emission in the PC treatment or Bacillus treatments, was lower than the NC treatment (p < 0.05). Breast pH, colour and water‐holding capacity were not affected by supplementation of B. subtilis RX7 and B2A. However, drip loss at 1 day post‐slaughter from birds fed with B. subtilis RX7 and B2A decreased, compared with the positive control birds (p < 0.05). Relative gizzard weights of birds fed B. subtilis RX7 and B2A were significantly higher than the NC birds under S. typhimurium challenge. It is concluded from the results that B. subtilis RX7 and B2A increased the gizzard weight and decreased the intestinal and excreta Salmonella population and excreta ammonia gas, and drip loss of breast meat after being stored for 1 day, under stress caused by the S. typhimurium challenge.     

Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs

Cefuroxime axetil pharmacokinetic profile was investigated in 12 Beagle dogs after single intravenous and oral administration of tablets or suspension at a dose of 20 mg/kg, under both fasting and fed conditions. A three-period, three-treatment crossover study (IV, PO under fasting and fed condition) was applied. Blood samples were withdrawn at predetermined times over a 12-hr period. Cefuroxime plasma concentrations were determined by HPLC. Data were analyzed by compartmental analysis. No statistically significant differences were observed between formulations and feeding conditions on PK parameters. Independently of the feeding condition, absorption of cefuroxime axetil after tablet administration was low and erratic. The drug has been quantified in plasma in 3 out of 6 and 5 out of 6 dogs in the fasted and fed groups. For this formulation, the bioavailability (F), peak plasma concentration (C_max), and area under the concentration–time curve (AUC) of cefuroxime axetil were significantly enhanced (p < .05) by the concomitant ingestion of food (32.97 ± 13.47–14.08 ± 7.79%, 6.30 ± 2.62–2.74 ± 0.66 µg/ml, and 15.75 ± 3.98–7.82 ± 2.76 µg.hr/ml for F, C_max, and AUC in fed and fasted dogs, respectively), while for cefuroxime axetil suspension, feeding conditions affected only the rate of absorption, as reflected by the significantly shorter absorption half-life (T_½(a)) and time to peak concentration (T_max) (0.55 ± 0.27–1.15 ± 0.19 hr and 1.21 ± 0.22–1.70 ± 0.30 for T_½(a) and T_max in fed and fasted dogs, respectively). For cefuroxime axetil tablets, T > MIC (≤1 µg/ml) was <2 hr in fasted and ≈4 hr in fed animals, and for cefuroxime axetil suspension, T > MIC (≤1 µg/ml) was ≈5 hr and for T >MIC (≤4 µg/ml) was ≈2.5 hr for fasted and fed dogs, respectively. Cefuroxime axetil as a suspension formulation seems to be a better option than tablets. However, its short permanence in plasma could reduce its clinical usefulness in dogs.